- Home
- IRON vs PAX Comparison
IRON vs PAX Comparison
Compare IRON & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- PAX
- Stock Information
- Founded
- IRON 2017
- PAX 1988
- Country
- IRON United States
- PAX Cayman Islands
- Employees
- IRON N/A
- PAX N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- PAX Investment Managers
- Sector
- IRON Health Care
- PAX Finance
- Exchange
- IRON Nasdaq
- PAX Nasdaq
- Market Cap
- IRON 2.0B
- PAX 2.2B
- IPO Year
- IRON N/A
- PAX 2021
- Fundamental
- Price
- IRON $60.35
- PAX $13.42
- Analyst Decision
- IRON Strong Buy
- PAX Strong Buy
- Analyst Count
- IRON 11
- PAX 1
- Target Price
- IRON $95.73
- PAX $14.00
- AVG Volume (30 Days)
- IRON 325.5K
- PAX 484.0K
- Earning Date
- IRON 08-07-2025
- PAX 08-01-2025
- Dividend Yield
- IRON N/A
- PAX 6.48%
- EPS Growth
- IRON N/A
- PAX N/A
- EPS
- IRON N/A
- PAX 0.53
- Revenue
- IRON N/A
- PAX $397,504,000.00
- Revenue This Year
- IRON N/A
- PAX N/A
- Revenue Next Year
- IRON N/A
- PAX $22.27
- P/E Ratio
- IRON N/A
- PAX $25.56
- Revenue Growth
- IRON N/A
- PAX 26.52
- 52 Week Low
- IRON $30.82
- PAX $9.43
- 52 Week High
- IRON $68.73
- PAX $14.52
- Technical
- Relative Strength Index (RSI)
- IRON 57.22
- PAX 46.26
- Support Level
- IRON $57.54
- PAX $12.91
- Resistance Level
- IRON $64.83
- PAX $13.78
- Average True Range (ATR)
- IRON 2.14
- PAX 0.30
- MACD
- IRON -0.19
- PAX -0.06
- Stochastic Oscillator
- IRON 46.60
- PAX 45.54
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.